Sign in

You're signed outSign in or to get full access.

Jaime Vieser

Director at Alaunos Therapeutics
Board

About Jaime Vieser

Independent director since December 2020; age 55 as of April 30, 2025. Background spans high-yield trading and distressed credit: manager of Brushwood LLC; former Managing Partner and co-principal at Castle Hill Asset Management (2010–2017); led Deutsche Bank’s High Yield Sales & Trading in London (1998–2008); began at Bankers Trust in Investment Banking/Leveraged Finance (1994). Education: BA in Economics (University of Michigan) and MBA (SMU Cox School of Business). The Board cites his financial and investment expertise as qualifications for service.

Past Roles

OrganizationRoleTenureCommittees/Impact
Brushwood LLCManagerCurrentPrivate investment firm; financial and investment expertise leveraged on Board.
Castle Hill Asset Management LLCManaging Partner and co-principal2010–2017$2.7B AUM hedge fund focused on high yield/distressed; informs risk oversight.
Deutsche Bank (London)Head, High Yield Sales & Trading1998–2008Deep markets experience; relevant to audit/finance literacy.
Bankers Trust (New York)Investment Banking/Leveraged Finance1994–late 1990sFoundational credit and capital markets background.

External Roles

No other public company directorships disclosed for Vieser over the past five years in proxy biographies.

Board Governance

  • Board composition (as of April 30, 2025): Dale Curtis Hogue Jr. (Interim CEO/Director), Robert W. Postma (Director), Jaime Vieser (Director), Holger Weis (Director; Chair).
  • Independence: In 2024, all directors other than Hogue were independent under Nasdaq Rule 5605(a)(2); audit and corporate governance committee members (including Vieser) are independent.
  • Attendance: Board met 19 times in 2024; each current director attended ≥90% of Board and committee meetings. In 2023, Board met 43 times; each current director attended ≥75%. In 2022, Board met 14 times; each current director attended ≥90%.
  • Board leadership: Chair role separated from CEO; Weis appointed Chair Sept 22, 2023 (non-executive).

Committee Membership Matrix (2024)

CommitteeMembershipChair
AuditMember (Vieser) Chair: Holger Weis
CompensationNot a member (Vieser) 2024 Chair: Dr. Robert Hofmeister; resigned Apr 15, 2025; chair to be elected.
Corporate Governance & NominatingMember (Vieser) Chair: Robert W. Postma

Fixed Compensation

YearFees Earned or Paid in Cash ($)Option Awards ($)Stock Awards ($)Total ($)
2024$68,000 $12,815 $0 $80,815
2023$68,000 $35,260 $0 $103,260
2022$68,000 $56,350 $32,800 $157,150

Director Cash Fee Policy

ComponentAmount
Annual Board retainer$50,000 (paid quarterly in arrears)
Board Chair retainer$30,000 (annualized)
Audit Committee Chair$20,000; Member $12,000
Compensation Committee Chair$15,000; Member $9,000
Corporate Governance & Nominating Chair$10,000; Member $6,000

Performance Compensation

Director equity is time-based; no performance metrics are disclosed for non-employee directors.

Equity Award Structure and Vesting

Year/ProgramGrant TypeSharesGrant DateVesting
2024 AnnualStock options1,280 shares (annual); Board Chair additional 640 sharesJune 6, 20241/12 monthly over 12 months
2024 Initial (new directors)Stock options2,560 sharesVarious (at appointment)1/36 monthly over 36 months
2023 AnnualStock options100,000 shares per directorJune 6, 20231/12 monthly over 12 months
2023 Initial (new directors)Stock options150,000 shares (e.g., Hofmeister)2023 at appointment1/36 monthly over 36 months
2022 AnnualStock options; Restricted stock100,000 options; 40,000 RS (Chair received +40,000 RS)At annual meeting (2022)Options: equal monthly over 1 year; RS: vest in full at 1 year or next annual meeting

Other Directorships & Interlocks

  • WaterMill Settlement Agreement (Feb 4, 2021) obligated company to nominate Postma, Vieser, and Weis during the standstill period; agreement no longer in effect by 2024/2025. This reflects prior shareholder engagement/activism context rather than ongoing interlock.
  • No other public company boards disclosed for Vieser in the past five years.

Expertise & Qualifications

  • Financial and investment expertise; hedge fund and high-yield trading leadership; audit literacy affirmed by Board for audit committee members.
  • Education in economics and business (University of Michigan; SMU Cox MBA).

Equity Ownership

Beneficial Ownership Breakdown (as of April 30, 2025)

CategoryShares
Direct (Vieser)19,434
Brushwood LLC (manager)8,333
UTMA accounts (children)2,167
Options exercisable ≤60 days3,858
Total33,792 (2.02% of 1,639,521 shares outstanding)

Beneficial Ownership Trend

DateShares Beneficially Owned% of Outstanding
April 30, 202533,7922.02% (1,639,521 SO)
April 7, 2024228,943<1% (16,012,479 SO; footnoted breakdown includes options and warrants)
April 7, 20233,329,9791.38% (240,627,055 SO)
  • Shares pledged as collateral: not disclosed.

Insider Trades and Related-Party Participation

DateTransactionInstrumentQuantity/PriceParty
Nov 29, 2022Underwritten offering participation by affiliated entitiesCommon stock2,000,000 Firm Shares at $0.65 per share (pre-reverse split)Entities affiliated with Postma and Vieser
Nov 29, 2023 (disclosed in 2025 proxy)Underwritten offering participation by affiliated entitiesCommon stock13,333 Firm Shares at $97.50 per shareEntities affiliated with Postma and Vieser
  • Section 16(a) compliance: No delinquent reports in FY2024; in FY2023, late filings noted for Hofmeister only.

Governance Assessment

  • Board effectiveness: Vieser serves on Audit and Corporate Governance & Nominating, aligning with his finance/markets background; Board reports strong attendance (≥90% in 2024), supporting engagement.
  • Independence and conflicts: He is classified independent; related-party participation consisted of market-priced offering purchases by affiliated entities, reviewed under the company’s related-party policy—more a signal of support than operational conflict.
  • Compensation alignment: Cash fees modest; equity awards time-vested options (and 2022 RS) without performance metrics; ownership of 2.02% (2025) indicates “skin in the game,” though guidelines/pledging policies for directors are not disclosed.
  • RED FLAGS: None material identified for Vieser in proxies; note prior activist settlement context (WaterMill) and ongoing significant ownership by Postma—requires monitoring of governance dynamics but no adverse findings specific to Vieser.